Børresen-Dale AL - Search Results

1

BUB1 infrequently mutated in human breast carcinomas.

Langerød A, Strømberg M, Chin K, Kristensen VN, Børresen-Dale AL. Langerød A, et al. Hum Mutat. 2003 Nov;22(5):420. doi: 10.1002/humu.9194. Hum Mutat. 2003. PMID: 14517964

2

Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.

Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL. Laake K, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):175-80. Genes Chromosomes Cancer. 1997. PMID: 9071570

3

Screening for ESR mutations in breast and ovarian cancer patients.

Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL. Anderson TI, et al. Hum Mutat. 1997;9(6):531-6. doi: 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4. Hum Mutat. 1997. PMID: 9195227

4

Improved electrophoretic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide.

Kristensen VN, Børresen-Dale AL. Kristensen VN, et al. Biotechniques. 1997 Oct;23(4):634-6. doi: 10.2144/97234bm18. Biotechniques. 1997. PMID: 9343680 Free article. No abstract available.

5

Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. Virchows Arch. 1997 Nov;431(5):317-21. doi: 10.1007/s004280050105. Virchows Arch. 1997. PMID: 9463572

6

Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.

Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjaerg L, Dørum A, Møller P, Weber BL, Børresen-Dale AL. Andersen TI, et al. Hum Mutat. 1998;11(2):166-74. doi: 10.1002/(SICI)1098-1004(1998)11:2<166::AID-HUMU10>3.0.CO;2-X. Hum Mutat. 1998. PMID: 9482581

7

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.

Kristensen VN, Andersen TI, Lindblom A, Erikstein B, Magnus P, Børresen-Dale AL. Kristensen VN, et al. Pharmacogenetics. 1998 Feb;8(1):43-8. doi: 10.1097/00008571-199802000-00006. Pharmacogenetics. 1998. PMID: 9511180

8

High-throughput screening for known mutations by automated analysis of single sequencing reactions.

Kristensen T, Kristensen VN, Børresen-Dale AL. Kristensen T, et al. Biotechniques. 1998 May;24(5):832-5. doi: 10.2144/98245dt04. Biotechniques. 1998. PMID: 9591134 Free article.

9

Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases.

Sørlie T, Andersen TI, Bukholm I, Børresen-Dale AL. Sørlie T, et al. Breast Cancer Res Treat. 1998 Apr;48(3):259-64. doi: 10.1023/a:1005953519972. Breast Cancer Res Treat. 1998. PMID: 9598872

10

Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.

Bjørheim J, Lystad S, Lindblom A, Kressner U, Westring S, Wahlberg S, Lindmark G, Gaudernack G, Ekstrøm P, Røe J, Thilly WG, Børresen-Dale AL. Bjørheim J, et al. Mutat Res. 1998 Jul 17;403(1-2):103-12. doi: 10.1016/s0027-5107(98)00057-8. Mutat Res. 1998. PMID: 9726011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters